Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study
Stefan Walter1, Jessica R Marden, Laura D Kubzansky
1*Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco ∥Department of Medicine, Division of General Medical Disciplines, Stanford University, Stanford, CA Departments of †Social and Behavioral Sciences §Nutrition, Harvard School of Public Health, Boston, MA ‡Department of Medicine, Division of General Internal Medicine, University of Washington, Seattle, WA.
Background:
Mendelian Randomization (MR) studies have reported that type 2 diabetes (T2D) was not associated with Alzheimer disease (AD). We adopted a modified, mechanism-specific MR design to explore this surprising result.
Methods:
Using inverse-variance weighted MR analysis, we evaluated the association between T2D and AD using data from 39 single nucleotide polymorphisms (SNPs) significantly associated with T2D in DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) and the corresponding associations of each SNP with AD risk obtained from the International Genomics of Alzheimer's Project (IGAP, n=17,008 AD cases and n=37,154 controls). We evaluated mechanism-specific genetic subscores, including β-cell function, insulin sensitivity, and adiposity, and repeated analyses in 8501 Health and Retirement Study participants for replication and model validation.
Results:
In IGAP, the overall T2D polygenic score did not predict AD [odds ratio (OR) for the T2D polygenic score=1.01; 95% confidence interval (CI), 0.96, 1.06] but the insulin sensitivity polygenic score predicted higher AD risk (OR=1.17; 95% CI, 1.02, 1.34). In the Health and Retirement Study, polygenic scores were associated with T2D risk; the associations between insulin sensitivity genetic polygenic score and cognitive phenotypes were not statistically significant.
Conclusions:
Evidence from polygenic scores suggests that insulin sensitivity specifically may affect AD risk, more than T2D overall.
Insights
Type 2 diabetes (T2D) may not directly cause Alzheimer's disease (AD). However, impaired insulin sensitivity, a factor in T2D, appears to increase AD risk, suggesting a specific mechanism is involved.
Area of Science:
- Genetics
- Neuroscience
- Metabolic Disorders
Background:
- Previous Mendelian Randomization (MR) studies found no association between type 2 diabetes (T2D) and Alzheimer's disease (AD).
- This study investigates potential underlying mechanisms linking T2D and AD using a refined MR approach.
Purpose of the Study:
- To explore the surprising lack of association between T2D and AD reported in prior MR studies.
- To investigate if specific T2D-related mechanisms, such as insulin sensitivity, impact AD risk.
Main Methods:
- Employed inverse-variance weighted MR analysis using genetic data from large consortia (DIAGRAM, IGAP).
- Examined associations between T2D and AD using 39 single nucleotide polymorphisms (SNPs).
- Evaluated mechanism-specific genetic subscores (beta-cell function, insulin sensitivity, adiposity) and validated findings in the Health and Retirement Study.
Main Results:
- The overall T2D polygenic score did not predict AD risk in the International Genomics of Alzheimer's Project (IGAP).
- However, an insulin sensitivity polygenic score significantly predicted higher AD risk (OR=1.17, 95% CI: 1.02-1.34).
- Replication in the Health and Retirement Study showed polygenic scores associated with T2D risk, but insulin sensitivity's link to cognitive phenotypes was not significant.
Conclusions:
- Findings suggest insulin sensitivity, rather than T2D overall, may be a key factor influencing Alzheimer's disease risk.
- This highlights the importance of investigating specific pathophysiological pathways in complex disease associations.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pedigree Analysis
Genetic Lingo
